Second coronavirus vaccine rollout to be paused over blood clots concern
Published
Reports of rare and severe blood clots emerged in six women who had received the Johnson and Johnson jab
Full ArticlePublished
Reports of rare and severe blood clots emerged in six women who had received the Johnson and Johnson jab
Full ArticleThe coronavirus jab is linked to "extremely rare" blood clots
Johnson & Johnson has said it is delaying the rollout of its coronavirus vaccine in Europe amid a US probe into rare blood clots.